{
  "id": "ad1f2caa-679c-4e7b-94f5-22ab8ea685e5",
  "answer": "Egetis Therapeutics AB (publ) has a not yet measurable company news read. Its latest completed weekly trend is positive.",
  "status": "insufficient",
  "as_of": "2026-08-02T12:08:40.481877+00:00",
  "period_end": "2026-08-07",
  "scope": "company and instrument",
  "subject": {
    "type": "ticker",
    "key": "STO:EGTX",
    "name": "Egetis Therapeutics AB (publ) (EGTX)",
    "identity": {
      "sharemaestro_id": "ccdf6548-2eeb-48d2-a37a-8b3a542c0ba5",
      "canonical_name": "Egetis Therapeutics AB (publ)",
      "isin": null,
      "lei": null,
      "cik": null,
      "website": null,
      "aliases": [
        "EGTX"
      ],
      "provider_symbols": {
        "eodhd": [
          "EGTX.ST"
        ],
        "yahoo": "EGTX.ST",
        "market": "STO",
        "alpha_vantage": null
      },
      "same_as": []
    }
  },
  "coverage": {
    "country": "Sweden",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "score": 50.0,
  "confidence": 0,
  "evidence_count": 7,
  "independent_sources": 6,
  "freshest_evidence": null,
  "previous_read": 50.0,
  "change": 0.0,
  "method_version": "public-evidence-1",
  "facts": {
    "sector": "Healthcare",
    "ticker": "EGTX",
    "company": "Egetis Therapeutics AB (publ)",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Biotechnology",
    "week_end": "2026-08-07",
    "asset_type": "equity",
    "news_count": 7,
    "trend_state": "positive",
    "latest_close": "7.080000",
    "score_change": 0.0,
    "weekly_change": 18.0,
    "evidence_status": "insufficient",
    "sentiment_score": 50
  },
  "canonical_url": "https://sharemaestro.com/evidence/ad1f2caa-679c-4e7b-94f5-22ab8ea685e5/",
  "evidence_urls": [
    {
      "label": "Company chart",
      "url": "https://sharemaestro.com/terminal/ccdf6548-2eeb-48d2-a37a-8b3a542c0ba5/"
    },
    {
      "label": "Company news sentiment",
      "url": "https://sharemaestro.com/sentiment/ccdf6548-2eeb-48d2-a37a-8b3a542c0ba5/"
    },
    {
      "label": "Current financial news",
      "url": "https://sharemaestro.com/newsreel/search/?ticker=EGTX"
    }
  ],
  "limitations": "This is dated market research. Coverage may be delayed, incomplete or unavailable.",
  "record_hash": "0bce2e59e35c9a7f10293b280cb96da9e4925419bcfa2001f905da8292745800",
  "citation": "Sharemaestro, Egetis Therapeutics AB (publ) (EGTX), 2026-08-02, https://sharemaestro.com/evidence/ad1f2caa-679c-4e7b-94f5-22ab8ea685e5/"
}